NSE: EMAMILTD | BSE: 531162

Mid-range Performer

Download real time

542.05 3.80 (0.71%)

29.46% Fall from 52W High

573.4K NSE+BSE Volume

NSE 01 Oct, 2025 3:31 PM (IST)

23,660.5

Market Cap

Below industry Median

0.7

Beta 1Year

Very Low volatility

Emami Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for EMAMILTD, BSE:531162 Emami Ltd.

Emami Ltd.

29 Apr 2016

542.05

0.71%

Emami Ltd power brands continued to maintain leadership in key categories. Cooling Oils, Balms, Boroplus Antiseptic cream and Fair and Handsome maintained their leadership positions with 9M FY16 volume market shares at 60.5%, 56.2%, 77.7% and 62.6% respectively. New brand extensions - Fair and Handsome Complete Winter Solution and BoroPlus Cocoa Soft Moisturising Lotion launched recently are expected to add filip to its existing brand portfolio.

Promoters unpledged 2.89% of shares in last quarter. Total pledge stands at 10.50% of promoter holdings

Emami Ltd.

29 Jan 2016

542.05

0.71%

Emami 29Jan2016

Buy: Emami Ltd.

Phillip Capital

Delayed winter led to weak organic business growth of 4% and flattish volumes Price growth of 4% in the organic business despite deflation Gross margin saw strong expansion due to subdued commodity prices...

Promoters unpledged 2.89% of shares in last quarter. Total pledge stands at 10.50% of promoter holdings

Emami Ltd.

29 Jan 2016

542.05

0.71%

EARNINGS UPDATE - EMAMI

Buy: Emami Ltd.

Chola Wealth Direct

Background: Emami is a FMCG company with niche focus on relatively under penetrated segments such as antiseptic cream, fairness cream, talcum powder, cooling oil, pain balm and pain reliever. Emami's power brands such as Navratna Oil, Boroplus Cream, Zandu & MenthoPlus Balm, Fair & Handsome, Boroplus Powder, Navratna Cool Talc, Fast Relief, SonaChandi & Zandu accounts for 75% of company's sales. Emami sales and PAT have grown at a CAGR of 18.4% and 23.2% respectively (FY08-13). Geographical breakup of sales: North (29%), West (27%), South (23%) and East (21%). Export contributes ~10.4% of total revenue. Company...

Promoters unpledged 2.89% of shares in last quarter. Total pledge stands at 10.50% of promoter holdings

Emami Ltd.

29 Jan 2016

542.05

0.71%

Emami - 3QFY16 Result Update

Neutral: Emami Ltd.

Reliance Securities

Emami's numbers for 3QFY16 were marginally below our estimates. While net sales grew 13.9% to Rs7.9bn (our estimate of Rs8bn), EBITDA came in at Rs2.5bn, a growth of 18% yoy vs. our estimate of Rs2.7bn. Net profits for the quarter stood at Rs1.3bn, which was impacted by amortisation of goodwill arising from Kesh King acquisition. We estimate a 17.3% and 14.3% CAGR in revenues and earnings for...

Emami Ltd. has an average target of 763.29 from 7 brokers.

Emami Ltd.

11 Dec 2015

542.05

0.71%

Emami 11Dec2015

Buy: Emami Ltd.

Recommendation Target

Phillip Capital

Seasonal irregularities, the near term challenge: The onset of winter has been delayed across most parts of India and it will impact Q3FY16 sales for Emami as winter products form a bulk of its sales in Q3. Even during PC's ground view tour across various regions of India, it...

Promoters unpledged 2.89% of shares in last quarter. Total pledge stands at 10.50% of promoter holdings

Emami Ltd.

30 Oct 2015

542.05

0.71%

EARNINGS UPDATE - EMAMI

Sell: Emami Ltd.

Chola Wealth Direct

Emami Ltd. has an average target of 763.29 from 7 brokers.

Emami Ltd.

29 Oct 2015

542.05

0.71%

Emami - 2QFY16 Result Update

Neutral: Emami Ltd.

Reliance Securities

Emami reported 17.4% growth in consolidated topline to Rs5.7bn. This was lower than our estimate of Rs6.3bn. EBITDA grew by 34.2% to Rs1.5bn in line with our estimate while reported net profit fell by 33.5% to Rs611mn on account of amortisation of Kesh King intangible assets for Rs620mn. Cash net profit increased by a healthy 30.3% in the quarter. Adjusting for the amortisation impact, EPS works out to Rs28.3 in FY17E. At the current price, the stock is trading at price earnings...

Emami Ltd. is trading below all available SMAs

Is Emami Ltd. worth buying?

225 Votes:

Buy 74.67%

Sell 17.33%

Hold 8.0%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf